-
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER TrialMurphy SA, Pedersen TR, Gaciong ZA et al. -
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)F Mach, C Baigent, ESC Scientific Document Group et al.
-
Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory DiseaseF Moroni, E Ammirati, AH Hainsworth et al.
-
The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization studyI Verkouter, R de Mutsert, RAJ Smit et al.
-
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-ITDL Bhatt, G Steg, and on behalf of the REDUCE-IT Investigators.
-
Coronary calcium as a predictor of coronary events in four racial or ethnic groupsDetrano R, Guerci AD, Carr JJ et al.
-
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome dataOikonomou EK, Marwan M, Antoniades C et al.
-
Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young AdultsMiedema MD, Dardari ZA, Nasir K et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
